Racemic Dolutegravir D6 - Request Quote
Racemic Dolutegravir D6
| SZ CAT No: | SZ-D052D04 |
| CAS No | NA |
| Mol.F. | C20H13D6F2N3O5 |
| Mol.Wt. | 425.4 |
| Inv. Status | Limited Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Racemic Dolutegravir D6 is chemically N-(2,4-difluorobenzyl)-7-hydroxy-4-(methyl-d3)-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-3,3,4-d3-9-carboxamide. Racemic Dolutegravir D6 is supplied with detailed characterization data compliant with regulatory guideline. Racemic Dolutegravir D6 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dolutegravir.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Racemic Dolutegravir D6
Purchase Racemic Dolutegravir D6
Racemic Dolutegravir D6 suppliers
Racemic Dolutegravir D6 manufacturers
Racemic Dolutegravir D6 price
Order Racemic Dolutegravir D6
Enquire Racemic Dolutegravir D6
Racemic Dolutegravir D6 cost
Racemic Dolutegravir D6 Supplier
Racemic Dolutegravir D6 Distributor
Racemic Dolutegravir D6 for Method Validation
Dolutegravir Reference Standard
Racemic Dolutegravir D6 for ANDA Filing
Racemic Dolutegravir D6 for Forced Degradation Studies
Racemic Dolutegravir D6 Identification Standards
Racemic Dolutegravir D6 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


